Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Atrial Fibrillation Management and Outcomes
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the management, treatment, and risk assessment of atrial fibrillation (AF). It covers topics such as anticoagulant therapy, catheter ablation, stroke prevention, risk stratification, and guidelines for managing AF. The papers also compare different medications such as warfarin, rivaroxaban, and dabigatran for the treatment of AF.
662
Works
IDs:OpenAlex
How has Atrial Fibrillation Management and Outcomes's publication output changed over time?
ScholarIQpublication output · 1998–2020
Output grew0% over the shown period — from 1 works in 1998 to 1 in 2020.
1
2
1
1
2
1
2
2
2
1
1998200120092010201120122013201420162020
What are the most-cited papers on Atrial Fibrillation Management and Outcomes?
ScholarIQmost cited works
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, John W. Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul Reilly, Ellison Themeles, Jeanne Varrone, Susan Wang, Marco Alings, Denis Xavier, Jun Zhu, Rafael Díaz, Basil S. Lewis, Harald Darius, Hans‐Christoph Diener, Campbell Joyner, Lars Wallentin
New England Journal of Medicine. 200911,232 CitationsOPEN ACCESS
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, Elena Arbelo, Jeroen J. Bax, Carina Blomström‐Lundqvist, Giuseppe Boriani, Manuel Castella, Gheorghe-Andrei Dan, Polychronis Dilaveris, Laurent Fauchier, Gerasimos Filippatos, Jonathan M Kalman, Mark La Meir, Deirdre A Lane, Jean‐Pierre Lebeau, Maddalena Lettino, Gregory Y.H. Lip, Fausto J Pinto, G. Neil Thomas, Marco Valgimigli, Isabelle C. Van Gelder, Bart P. van Putte, Caroline Watkins, ESC Scientific Document Group, Paulus Kirchhof, Michael Kühne, Victor Aboyans, Anders Ahlsson, Paweł Balsam, Johann Bauersachs, Stefano Benussi, Axel Brandes, Frieder Braunschweig, A John Camm, Davide Capodanno, Barbara Casadei, David Conen, Harry J.G.M. Crijns, Victoria Delgado, Dobromir Dobrev, Heinz Drexel, Lars Eckardt, Donna Fitzsimons, Thierry Folliguet, Chris P Gale, Bülent Görenek, Karl Georg Hæusler, Hein Heidbüchel, Bernard Iung, Hugo A Katus, Dipak Kotecha, Ulf Landmesser, Christophe Leclercq, Basil S. Lewis, Julia Mascherbauer, José Luís Merino, Béla Merkely, Lluı́s Mont, Christian Mueller, Klaudia V Nagy, Jonas Oldgren, Nikola Pavlović, Roberto F.E. Pedretti, Steffen E. Petersen, Jonathan P. Piccini, Bogdan A Popescu, Helmut Pürerfellner, Dimitrios J. Richter, Marco Roffi, Andrea Rubboli, Daniel Scherr, Renate B. Schnabel, Iain A. Simpson, Е. V. Shlyakhto, Moritz F. Sinner, Jan Steffel, Miguel Sousa-Uva, Piotr Suwalski, Martin Svetlošák, Rhian M Touyz, Nikolaos Dagres, Elena Arbelo, Jeroen J. Bax, Carina Blomström‐Lundqvist, Giuseppe Boriani, Manuel Castella, Gheorghe-Andrei Dan, Polychronis Dilaveris, Laurent Fauchier, Gerasimos Filippatos, Jonathan M Kalman, Mark La Meir, Deirdre A Lane, Jean‐Pierre Lebeau, Maddalena Lettino, Gregory Y.H. Lip, Fausto J Pinto, G. Neil Thomas, Marco Valgimigli
European Heart Journal. 202010,035 CitationsOPEN ACCESS
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg, Guohua Pan, Daniel E. Singer, Werner Hacke, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, John F. Paolini, Scott D. Berkowitz, Keith A.A. Fox, Robert M. Califf
New England Journal of Medicine. 20119,441 CitationsOPEN ACCESS
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray, Renato D. Lópes, Elaine M. Hylek, Michael G. Hanna, Hussein R. Al‐Khalidi, Jack Ansell, Dan Atar, Álvaro Avezum, M. Cecilia Bahit, Rafael Díaz, J. Donald Easton, Justin A. Ezekowitz, Greg Flaker, David García, Margarida Geraldes, Bernard J. Gersh, Golitsyn Sp, Shinya Goto, Antonio G. Hermosillo, Stefan H. Hohnloser, John D. Horowitz, Puneet Mohan, Petr Janský, Basil S. Lewis, José López‐Sendón, Prem Pais, Alexander Parkhomenko, Freek W.A. Verheugt, Jun Zhu, Lars Wallentin
New England Journal of Medicine. 20118,956 CitationsOPEN ACCESS
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Craig T. January, L. Samüel Wann, Joseph S. Alpert, Hugh Calkins, Joaquin E. Cigarroa, Joseph C. Cleveland, Jamie B. Conti, Patrick T. Ellinor, Michael D. Ezekowitz, Michael E. Field, Katherine T. Murray, Ralph L. Sacco, William G. Stevenson, Patrick Tchou, Cynthia M. Tracy, Clyde W. Yancy
Circulation. 20147,151 CitationsOPEN ACCESS
Where is Atrial Fibrillation Management and Outcomes research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Atrial Fibrillation Management and Outcomes is open access?
ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
13%
Hybrid
0%
Bronze
53%
Closed
33%
Related on ScholarIQ
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
Paper
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Paper
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Paper
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Paper
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Paper
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Paper